BiotechTube

Prograf + MR4

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Liver Transplantation

Conditions

Liver Transplantation

Trial Timeline

Feb 1, 2006 → Jun 1, 2008

NCT ID
NCT00719745

About Prograf + MR4

Prograf + MR4 is a phase 3 stage product being developed by Astellas Pharma for Liver Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT00719745. Target conditions include Liver Transplantation.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (2)

NCT IDPhaseStatus
NCT00720265Phase 3Completed
NCT00719745Phase 3Completed

Competing Products

20 competing products in Liver Transplantation

See all competitors
ProductCompanyStageHype Score
LanifibranorInventivaPhase 2
47
GODEX + PlaceboCelltrionPhase 3
77
peginterferon alfa-2a 180μg + peginterferon alfa-2a 90μg + ribavirinChugai PharmaceuticalPhase 3
77
exatecan mesylateDaiichi SankyoPhase 2
52
TacrolimusAstellas PharmaPre-clinical
23
ATG (Fresenius Biotech)Astellas PharmaPhase 2
52
Advagraf + Prograf + PrografAstellas PharmaApproved
85
Prograf + AdvagrafAstellas PharmaApproved
85
ADVAGRAF®Astellas PharmaApproved
85
tacrolimus modified release (MR) + tacrolimusAstellas PharmaPhase 2
52
tacrolimus modified release (MR) + tacrolimusAstellas PharmaPhase 2
52
tacrolimusAstellas PharmaPhase 3
77
Prograf-XL + Prograf + MMFAstellas PharmaPhase 3
77
micafungin + fluconazole + liposomal amphotericin B + caspofunginAstellas PharmaPhase 3
77
Tacrolimus granules + Tacrolimus granulesAstellas PharmaApproved
85
FK506E (modified release tacrolimus) + Prograf (tacrolimus)Astellas PharmaPhase 3
77
FK778Astellas PharmaPhase 2
52
Tacrolimus modified-release + PrografAstellas PharmaPhase 3
77
Advagraf + PrografAstellas PharmaApproved
85
Prograf + FK506MR capsuleAstellas PharmaPhase 3
77

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85